DossierENTITY

rejuvenation drugs

Coverage of rejuvenation drugs in the Nexus archive.

Earliest in view: Jun 9 · 12:10 UTCMost recent: Jun 9 · 12:10 UTC

Co-mentioned in this coverage

Recent coverage

TECHNOLOGYJun 9 · 12:10 UTCMIT TECHNOLOGY REVIEW
The Download: whole-body rejuvenation drugs and five things to know about AI
David Sinclair plans to test whole-body rejuvenation drugs in a $101 million XPrize competition aiming to reverse aging through human trials. The article also covers AI developments, including OpenAI's confidential IPO filing and U.S.-China tech tensions involving companies like BYD and Baidu.